These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Universities shun Europe's drug initiative. Gilbert N Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770 [No Abstract] [Full Text] [Related]
3. Scepticism greets EU plan for virtual institute. Schiermeier Q Nature; 2006 Mar; 440(7080):8-9. PubMed ID: 16511455 [No Abstract] [Full Text] [Related]
4. Academia-pharma partnerships for novel drug discovery: essential or nice to have? Palmer M; Chaguturu R Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189 [No Abstract] [Full Text] [Related]
5. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation. Patel AC; Coyle AJ Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247 [No Abstract] [Full Text] [Related]
7. Funding bodies should foster partnerships between industry and academia. Tzircotis G; Hickson T; Foulkes I Nat Rev Cancer; 2021 Feb; 21(2):65-66. PubMed ID: 33398101 [No Abstract] [Full Text] [Related]
8. The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità. Ingrosso L; Rezza G; Pocchiari M; Garaci E Ann Ist Super Sanita; 2012; 48(2):115-6. PubMed ID: 22751551 [No Abstract] [Full Text] [Related]
9. [Development of synergies and partnerships on rare diseases: model of a scientific cooperation foundation]. Lévy N Presse Med; 2012 May; 41 Suppl 1():S23-5. PubMed ID: 22483766 [No Abstract] [Full Text] [Related]
10. Alzheimer's disease public-private partnerships: A landscape of the global nonprofit community. Snyder HM; Bain LJ; Egge R; Carrillo MC Alzheimers Dement; 2013 Jul; 9(4):466-71. PubMed ID: 23809367 [No Abstract] [Full Text] [Related]
11. Europe's research system must change. Georghiou L Nature; 2008 Apr; 452(7190):935-6. PubMed ID: 18432225 [No Abstract] [Full Text] [Related]
12. Transdisciplinary EU science institute needs funds urgently. Vasbinder JW; Andersson B; Arthur WB; Boasson M; de Boer R; Changeux JP; Domingo E; Eigen M; Fersht A; Frenkel D; Rees M; Groen T; Huber R; Hunt T; Holland J; May R; Norrby E; Nijkamp P; Lehn JM; Rabbinge R; Scheffer M; Schuster P; Serageldin I; Stuip J; de Vries J; van Vierssen W; Willems R Nature; 2010 Feb; 463(7283):876. PubMed ID: 20164899 [No Abstract] [Full Text] [Related]
13. Europe sees mixed results from public-private partnerships for building and managing health care facilities and services. Barlow J; Roehrich J; Wright S Health Aff (Millwood); 2013 Jan; 32(1):146-54. PubMed ID: 23297282 [TBL] [Abstract][Full Text] [Related]
14. Policy forum: European policy. Interesting times--biology, European science, and EMBL. Kafatos FC Science; 2000 Feb; 287(5457):1401, 1403. PubMed ID: 10722387 [No Abstract] [Full Text] [Related]
15. Infectious disease leads in first phase of Europe's IMI effort. Nat Med; 2014 Jan; 20(1):5. PubMed ID: 24398949 [No Abstract] [Full Text] [Related]
16. European Union. Political crisis puts Europe's research ambitions in doubt. Enserink M Science; 2005 Jun; 308(5730):1848-9. PubMed ID: 15976274 [No Abstract] [Full Text] [Related]
17. Science funding. At long last, Europe's mega R&D program comes into focus. Rabesandratana T; Vogel G Science; 2013 Jul; 341(6141):21. PubMed ID: 23828923 [No Abstract] [Full Text] [Related]
18. Science in Europe. The new framework for EU research and innovation. Horvat M Science; 2011 Nov; 334(6059):1066-8. PubMed ID: 22116869 [No Abstract] [Full Text] [Related]
19. The innovative medicines initiative: a European response to the innovation challenge. Goldman M Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619 [TBL] [Abstract][Full Text] [Related]